ABBV NYSE Week ended 31 Jul 2026

Weekly Investor Report

AbbVie Inc · Healthcare · Drug Manufacturers - General

Open interactive chart View report data
Latest close 250.9 USD
-3.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 12.5% above the Trend Line and sits at 78.9% of its 52-week range. The latest completed week returned -3.2%, after a -3.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 40/100 conviction, while the latest news-sentiment score is 50/100.

Setup score 54 out of 100
Latest Close 250.9 USD 31 Jul 2026
1W Return -3.2% latest completed week
4W Return -3.2% short-term follow-through
12W Return 24.5% quarterly tape
Trend Breadth 69.2% 36 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
  • Latest weekly return ranks in the weaker part of its sector group.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.2% Latest completed week; four-week move -3.2%. Indicator stack 55/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 40/100 conviction; expected move 3.2%. News sentiment 50/100 45 relevant articles in the latest sentiment read. Event risk 31 Jul Latest stored earnings date was 31 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 12.5% above the Trend Line and sits at 78.9% of its 52-week range. The latest completed week returned -3.2%, after a -3.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6812-week average 0.32

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -3.2% over four weeks, 24.5% over 12 weeks, and 31.6% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W-3.2%
4W-3.2%
12W24.5%
26W13.5%
52W31.6%
Active trend streak5 weeks
Active weeks in one year36
Trend breadth69.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.07Latest activity-pressure read.
Pressure change14.7%Four-week change in activity pressure.
Leadership4.40Latest relative-leadership reading.
RS change-51.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength34/100Blend of value, momentum, and quality. Underlying universe rank 67; rank 1 is best.
Value6/100Relative valuation strength. Underlying universe rank 95; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth13/100Revenue and earnings growth. Underlying universe rank 88; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
125.9x
Price divided by trailing earnings.
Price / sales
7.3x
Market value relative to trailing revenue.
EV / EBITDA
30.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
70.7%
Gross profit retained from each unit of revenue.
Operating margin
14.1%
Operating profit retained from revenue.
Free-cash-flow margin
36.0%
Free cash flow generated from revenue.
Return on invested capital
9.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
9.5%
Latest one-year revenue growth.
EPS growth
-13.3%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
29.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.6%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
2.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

ABBV shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.71, expected move of 3.2%, and Sharemaestro trend signal active.

Conviction40/100
Expected move3.2%
Put/call volume0.71
Pressure19
Speculation43
Volatility32
Trend agreement74
Open options detail
Insider activity16 / 0

16 acquisitions and 0 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 45 relevant articles.

10 positive · 26 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings31 JulLatest stored earnings date was 31 Jul 2026.
Options expected move3.2%Nearest-chain priced movement where available.
52-week drawdown-6.2%Distance below the 52-week high.
13-week volatility5.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+17.0%Week of 26 Jun.
Worst week-6.7%Week of 20 Mar.
Latest week-3.2%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains11
Flat weeks0
Modest losses7
Sharp losses5
Recent vol5.5%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis51/100

Latest 12-week confirmation: trend 5/12, activity pressure 8/12, relative leadership 6/12.

Activity pressure 0.68; 2 reversal markers Factors48/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options62/100

ABBV shows bullish options pressure with a 40/100 conviction score, put-call volume ratio of 0.71, expected move of 3.2%, and Sharemaestro trend signal active.

Bullish · Call-side pressure · Expected move 3.2% Sentiment50/100

Weighted news tone is neutral across 45 relevant articles.

Why AbbVie Stock Slumped Today Insiders16 / 0

16 acquisitions and 0 disposals in the latest 180-day insider tape.

 Earnings31 Jul

Latest stored earnings date was 31 Jul 2026.

 Research flow4 items

1 recent research articles and 3 Market Watch posts are available.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026250.9 USD-3.2%223.1 USD183.6 USD1.074.4031.7MOn
24 Jul 2026259.4 USD1.9%222.2 USD182.8 USD1.169.2622.9MOn
17 Jul 2026254.5 USD3.3%221.1 USD182.0 USD1.286.9429.2MOn
10 Jul 2026246.3 USD-5.0%220.1 USD181.2 USD1.092.1835.7MOn
3 Jul 2026259.2 USD3.0%219.2 USD180.4 USD0.949.1630.9MOn
26 Jun 2026251.6 USD17.0%218.0 USD179.6 USD0.758.5787.5MOff
19 Jun 2026215.0 USD-4.9%217.0 USD178.7 USD0.33-9.1326.5MOff
12 Jun 2026226.1 USD-0.5%217.6 USD178.1 USD0.06-3.6322.0MOff
5 Jun 2026227.2 USD4.4%217.7 USD177.5 USD-0.28-2.6629.4MOff
29 May 2026217.7 USD0.9%217.3 USD176.8 USD-0.78-9.0822.2MOff
22 May 2026215.7 USD2.5%217.2 USD176.2 USD-0.94-8.7326.2MOff
15 May 2026210.4 USD4.4%217.5 USD175.6 USD-1.01-10.3128.1MOff
8 May 2026201.6 USD-2.4%218.0 USD175.1 USD-1.03-14.0028.0MOff
1 May 2026206.6 USD4.0%218.8 USD174.6 USD-0.99-10.0240.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.